Non-randomized evaluation studies (TREND);Estudios de intervención no aleatorizados (TREND)

Medicina Clinica

Volumn 125, Issue SUPPL. 1, 2005, Pages 38-42

  Vallvé, Carles ^a,e   Artés, Maite ^b   Cobo, Erik ^c,d  

^a Farmacólogo Clínico   (Spain)

^b Adelphi Targis SL   (Spain)

^c UNIVERSITAT POLITÈCNICA DE CATALUNYA   (Spain)

^d Comité Editorial de Medicina Clínica ^*  (Spain)

^e NONE   (Spain)

Author keywords

Checklists; Effectiveness; Efficacy; Nonrandomized trials; TREND

Indexed keywords

ARTICLE; CHECKLIST; MEDICAL LITERATURE; PROFESSIONAL PRACTICE; RANDOMIZED CONTROLLED TRIAL;

AUTHORSHIP; CHECKLIST; CLINICAL TRIALS AS TOPIC; EVALUATION STUDIES AS TOPIC; INTERVENTION STUDIES; PERIODICALS AS TOPIC; PUBLISHING; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH REPORT;

EID: 34547737931     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1157/13076407     Document Type: Letter

References (14)

1. Meehl PE. The power of quantitative thinking. Speech delivered upon receipt of the James McKeen Cattell Fellow award at the meeting of the American Psychological Society (1998, May 23rd).
2. Smith GCS, Pell JP. Parachute use to prevent death and major trauma related to gravitional challenge: systematic review of randomised controlled trials. BMJ. 2003;327:1459-61.
3. Sandell R, Blomberg J, Lazar A, Carlsson J, Broberg J, Rand H. Varieties of long-term outcome among patients in psychoanalysis and long-term psychotherapy: a review of findings of the Stockholm outcome of psychoanalysis and psychotherapy project (STOPPP). Int J Psychoanal. 2000;81:921-43.
4. Doidge N. Empirical evidence for the efficacy of psychoanalytic psychotherapies and psychoanalysis: An overview. Psychoanal Inq. 1997;17S:102-50.
5. Hill MN. New targeted AHA research program. Cardiovascular care and outcomes. Circulation. 1998;97:1221-2.
6. Victora CG, Habicht JP, Bryce J. Evidence-based public health: moving beyond randomized trials. Am J Public Health. 2004;94:400-5.
7. Vallvé C. Revisión crítica del ensayo clínico pragmático. Med Clin (Barc). 2003;121:384-8.
8. Bayarri MJ, Cobo E. Una oportunidad para Bayes. Med Clin (Barc). 2002;119:252-3.
9. Topol EJ. Failing the public health. Rofecoxib, Merck, and the FDA. NEJM. 2004;351:1707-9.
10. Des Jarlais DC, Lyles C, Crepaz N, and the TREND Group. Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: The TREND statement. Am J Public Health. 2004;94:361-6.
11. Kirkwood B. Making public health interventions more evidence based BMJ. 2004;328:966-7.
12. Campbell MK, Elbourne DR, Altman DG. Ensayos clínicos aleatorizados comunitarios: (CONSORT CLUSTER). Med Clin (Barc). 2005;125 Supl 1:28-31.
13. Deeks JJ, Dignes J, D'Amico R, Sowden AJ. Sakarovitch C, Song F, et al. Evaluating non-randomised intervention studies. Health Technol Asess. 2003;7:1-173.
14. Altman DG, Schultz KF, Moher D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med. 2001;134:663-94.